|Childhood cancer survival in Europe 1999–2007: results of EUROCARE-5—a population-based study|
G Gatta, L Botta, S Rossi, T Aareleid, M Bielska-Lasota, J Clavel, ...
The lancet oncology 15 (1), 35-47, 2014
|Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study|
G Gatta, L Botta, MJ Sánchez, LA Anderson, D Pierannunzio, L Licitra, ...
European journal of cancer 51 (15), 2130-2143, 2015
|Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study|
G Gatta, R Capocaccia, L Botta, S Mallone, R De Angelis, E Ardanaz, ...
The Lancet Oncology 18 (8), 1022-1039, 2017
|Survival of women with cancers of breast and genital organs in Europe 1999–2007: results of the EUROCARE-5 study|
M Sant, MDC Lopez, R Agresti, MJS Pérez, B Holleczek, ...
European journal of cancer 51 (15), 2191-2205, 2015
|Survival of European adolescents and young adults diagnosed with cancer in 2000–07: population-based data from EUROCARE-5|
A Trama, L Botta, R Foschi, A Ferrari, C Stiller, E Desandes, MM Maule, ...
The Lancet Oncology 17 (7), 896-906, 2016
|Survival for oesophageal, stomach and small intestine cancers in Europe 1999–2007: results from EUROCARE-5|
LA Anderson, A Tavilla, H Brenner, S Luttmann, C Navarro, AT Gavin, ...
European Journal of Cancer 51 (15), 2144-2157, 2015
|Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999–2007: results of EUROCARE-5|
C Lepage, R Capocaccia, M Hackl, V Lemmens, E Molina, ...
European Journal of Cancer 51 (15), 2169-2178, 2015
|On-going improvement and persistent differences in the survival for patients with colon and rectum cancer across Europe 1999–2007–results from the EUROCARE-5 study|
B Holleczek, S Rossi, A Domenic, K Innos, P Minicozzi, S Francisci, ...
European Journal of Cancer 51 (15), 2158-2168, 2015
|The EUROCARE-5 study on cancer survival in Europe 1999–2007: Database, quality checks and statistical analysis methods|
S Rossi, P Baili, R Capocaccia, M Caldora, E Carrani, P Minicozzi, ...
European journal of cancer 51 (15), 2104-2119, 2015
|Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000–2007: Results of EUROCARE-5 population-based study|
R De Angelis, P Minicozzi, M Sant, L Dal Maso, DH Brewster, ...
European Journal of Cancer 51 (15), 2254-2268, 2015
|Survival patterns in lung and pleural cancer in Europe 1999–2007: results from the EUROCARE-5 study|
S Francisci, P Minicozzi, D Pierannunzio, E Ardanaz, A Eberle, ...
European Journal of Cancer 51 (15), 2242-2253, 2015
|Survival of male genital cancers (prostate, testis and penis) in Europe 1999–2007: Results from the EUROCARE-5 study|
A Trama, R Foschi, N Larrañaga, M Sant, R Fuentes-Raspall, D Serraino, ...
European Journal of Cancer 51 (15), 2206-2216, 2015
|Survival of patients with skin melanoma in Europe increases further: results of the EUROCARE-5 study|
E Crocetti, S Mallone, TE Robsahm, A Gavin, D Agius, E Ardanaz, ...
European Journal of Cancer 51 (15), 2179-2190, 2015
|Urinary tract cancer survival in Europe 1999–2007: results of the population-based study EUROCARE-5|
R Marcos-Gragera, S Mallone, LA Kiemeney, L Vilardell, N Malats, ...
European Journal of Cancer 51 (15), 2217-2230, 2015
|Survival of 86,690 patients with thyroid cancer: a population-based study in 29 European countries from EUROCARE-5|
L Dal Maso, A Tavilla, F Pacini, D Serraino, BAC Van Dijk, MD Chirlaque, ...
European Journal of Cancer 77, 140-152, 2017
|Age and case mix-standardised survival for all cancer patients in Europe 1999–2007: Results of EUROCARE-5, a population-based study|
P Baili, F Di Salvo, R Marcos-Gragera, S Siesling, S Mallone, ...
European Journal of Cancer 51 (15), 2120-2129, 2015
|Survival of adults with primary malignant brain tumours in Europe; Results of the EUROCARE-5 study|
O Visser, E Ardanaz, L Botta, M Sant, A Tavilla, P Minicozzi, M Hackl, ...
European Journal of Cancer 51 (15), 2231-2241, 2015
|Chordoma: update on disease, epidemiology, biology and medical therapies|
AM Frezza, L Botta, A Trama, AP Dei Tos, S Stacchiotti
Current opinion in oncology 31 (2), 114-120, 2019
|The effect of glutamate on the frog semicircular canal|
P Valli, G Zucca, I Prigioni, L Botta, C Casella, PS Guth
Brain research 330 (1), 1-9, 1985
|The Role of Endothelial Ca2+ Signaling in Neurovascular Coupling: A View from the Lumen|
G Guerra, A Lucariello, A Perna, L Botta, AD Luca, F Moccia
International journal of molecular sciences 19 (4), 938, 2018